Validation of the Persian Version of Inflammatory Bowel Disease Questionnaire in Patients Who Referred to Clinics and Hospitals of Birjand University of Medical Sciences, Iran

Document Type : Research/Original Article

Authors

1 Associate Professor, Department of Community Medicine, Birjand University of Medical Sciences, Birjand, Iran

2 MD, Birjand University of Medical Sciences, Birjand, Iran

Abstract

Background: Inflammatory bowel disease (IBD) questionnaire is a disease-specific questionnaire to measure the health related quality of life (QOL) in patients with inflammatory bowel disease.
Objectives: The current study aimed at assessing the validity of the Persian version of the QOL questionnaire in patients with inflammatory bowel disease referred to the clinics and hospitals affiliated to Birjand University of Medical Sciences, Iran.
Methods: The current cross sectional study included 87 patients who referred to the clinics and hospitals affiliated to Birjand University of Medical Sciences from 2014 to 2015; IBD diagnosis was confirmed in the subjects by the pathological analyses and accordingly they were asked to complete the Persian version of IBDQ. Data were analyzed by SPSS (15) using descriptive statistics, internal
consistency reliability, construct validity (by the short-form 36), and factor analysis was used for the structural validity of the questionnaire.
Results: A total of 87 patients with the mean age of 38.80 ± 16.17 years enrolled in the study. Mean score of QOL based on IBDQ questionnaire, was 158.99 ± 24.9 out of 224. The factor analysis of the Persian version did not confirm the structural factor of the original questionnaire. Cronbach’s alpha for the questionnaire was 0.94, in domains from 0.68 to 0.89. The correlation between the domains of QOL in IBDQ and SF-36 inventory were 0.44 to 0.69
Conclusions: Due to the high internal consistency and correlation coefficients with SF-36 inventory, it can be used in the studies to evaluate the QOL in the patients.

Keywords


1.Knowles SR, Austin DW, Sivanesan S, Tye-Din J, Leung C, Wilson J, et al. Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness. Psychol Health Med. 2017;22(5):524–34. doi: 10.1080/13548506.2016.1168932. [PubMed: 27045996].
2. Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol. 2013;29(4):357–62. doi: 10.1097/MOG.0b013e32836229fb. [PubMed: 23695429].
3. Jordan C, Sin J, Fear NT, Chalder T. A systematic review of the psychological correlates of adjustment outcomes in adults with inflammatory bowel disease. Clin Psychol Rev. 2016;47:28–40. doi: 10.1016/j.cpr.2016.06.001. [PubMed: 27318795].
4. Umanskiy K, Fichera A. Health related quality of life in inflammatory bowel disease: the impact of surgical therapy. World J Gastroenterol. 2010;16(40):5024–34. [PubMed: 20976838].
5. Gholamrezaei A, Haghdani S, Shemshaki H, Tavakoli H, Emami MH. Linguistic validation of the inflammatory bowel disease questionnaire-short form (IBDQ-9) in Iranian population. J Isfahan Med School. 2011;28(123).
6. Nejat S. Quality of Life and its Measurement. irje. 2008;4(2):57–62.
7. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res. 2005;14(3):875–82. [PubMed: 16022079].
8. Hjortswang H, Jarnerot G, Curman B, Sandberg-Gertzen H, Tysk C, Blomberg B, et al. Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 2001;36(1):77–85. [PubMed: 11218243].
9. Cheung W, Garratt AM, Russell IT, Williams JG. The UK IBDQ-A British version of the inflammatory bowel disease questionnaire. J Clin Epidemiol. 2000;53(3):297–306. doi: 10.1016/s0895-4356(99)00152-3.
10. Pallis AG, Mouzas IA, Vlachonikolis IG. The inflammatory bowel disease questionnaire: a review of its national validation studies. Inflamm Bowel Dis. 2004;10(3):261–9. [PubMed: 15290922].
11. Hauser W, Dietz N, Grandt D, Steder-Neukamm U, Janke KH, Stein U, et al. Validation of the inflammatory bowel disease questionnaire IBDQD, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis. Z Gastroenterol. 2004;42(2):131–9. doi: 10.1055/s2004-812835. [PubMed: 14963785].
12. Ren WH, Lai M, Chen Y, Irvine EJ, Zhou YX. Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis. 2007;13(7):903–10. doi: 10.1002/ibd.20128. [PubMed: 17309070].
13. Pallis AG, Vlachonikolis IG, Mouzas IA. Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece. BMC Gastroenterol. 2002;2:1. [PubMed: 11866863].
14. Leong R, Lee YT, Ching J, Sung J. Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the inflammatory bowel disease questionnaire. Aliment Pharmacol Ther. 2003;17(5):711–8.
15. Maleki I, Taghvaei T, Barzin M, Amin K, Khalilian A. Validation of the Persian version of the inflammatory bowel disease questionnaire (IBDQ) in ulcerative colitis patients. Caspian J Intern Med. 2015;6(1):20– 4. [PubMed: 26221492].
16. Verissimo R. Quality of life in inflammatory bowel disease: psychometric evaluation of an IBDQ cross-culturally adapted version. J Gastrointestin Liver Dis. 2008;17(4):439–44. [PubMed: 19104706]